Julien Beyrath

Julien Beyrath

Julien is a drug translational scientist with 15 years experience bridging academic and biotech environments. Driven by science and author of several peer-reviewed scientific publications and patents in different disease indications, he is keen to facilitate the translation of valuable therapeutic discoveries into clinical applications to answer true medical problems.
Julien enjoys multidisciplinary approaches in drug development and along his career he has become at ease spanning from early discovery, medicinal chemistry, IND-enabling studies, CMC to regulatory interaction. He has a strong focus on drug target and mode of action deconvolution together with (pre)clinical translating biomarkers identification in order to increase clinical trial success rate.

Prior to joining Curare Consulting, Julien held executive positions as COO and CSO at Khondrion – a clinical stage biopharmaceutical company developing therapies targeting rare mitochondrial diseases -, leading cross-functional and multicultural teams to translate a drug candidate from the laboratory bench up to phase IIb clinical trials. As such Julien is very much acquainted with the specifics of developing a compound for orphan indications

Julien earned is PhD (2010) in Molecular and Cellular Biology and his MSc. (2006) in Pharmacology at the University of Strasbourg, France.